Circulation & Vein Support for Healthy Legs
Withdrawn from the US market on 14 February 2025 (according to the DSLD)
ProCaps Laboratories, food supplement from the US market
Label withdrawn from the US market. Circulation & Vein Support for Healthy Legs (ProCaps Laboratories), a food supplement without a usable barcode in DSLD, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- ProCaps Laboratories
- Barcode
- Not provided or invalid in DSLD
- Form
- Capsule
- One serving
- 2 capsules
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Gelatin
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Vitamin C | Vitamin | 30 mg |
| Diosmin | Other substance | 600 mg |
| Butcher's Broom Rhizome, Root Extract (Ruscus aculeatus) | Plant | 80 mg |
| Horse Chestnut Seed Extract (Aesculus hippocastanum) | Plant | 80 mg |
| Pine Bark Extract | Plant | 10 mg |
| Grape Seed Extract | Plant | 10 mg |
| Hesperidin | Other substance | 50 mg |
| Rutin | Other substance | 10 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Circulation & Vein Support for Healthy Legs
Entered into DSLD on 22 May 2020. Withdrawn from the US market on 19 March 2021 (according to the DSLD).- Active ingredient added : Butcher's Broom extract (40 mg)
- Active ingredient added : Total Flavonoids (720 mg)
- Active ingredient removed : Butcher's Broom Rhizome, Root Extract (80 mg)
- Active ingredient removed : Horse Chestnut Seed Extract (80 mg)
- Different quantity per serving : Grape Seed Extract: 40 mg in this version; 10 mg on the displayed label
- Different quantity per serving : Hesperidin: 100 mg in this version; 50 mg on the displayed label
- Different quantity per serving : Pine Bark extract: 40 mg in this version; 10 mg on the displayed label
- Different quantity per serving : Rutin: 20 mg in this version; 10 mg on the displayed label
Official label: Circulation & Vein Support for Healthy Legs
Entered into DSLD on 25 July 2018. Withdrawn from the US market on 2 April 2020 (according to the DSLD).- Active ingredient added : Butcher's Broom (80 mg)
- Active ingredient added : Grape (40 mg)
- Active ingredient added : Pine (40 mg)
- Active ingredient added : Total Flavonoids (720 mg)
- Active ingredient removed : Butcher's Broom Rhizome, Root Extract (80 mg)
- Active ingredient removed : Grape Seed Extract (10 mg)
- Active ingredient removed : Horse Chestnut Seed Extract (80 mg)
- Active ingredient removed : Pine Bark Extract (10 mg)
- Different quantity per serving : Hesperidin: 100 mg in this version; 50 mg on the displayed label
- Different quantity per serving : Rutin: 20 mg in this version; 10 mg on the displayed label
Official label: Circulation & Vein Support For Healthy Legs
Entered into DSLD on 25 January 2017. Withdrawn from the US market on 30 January 2018 (according to the DSLD).- Active ingredient added : Butcher’s Broom (40 mg)
- Active ingredient added : Grape (40 mg)
- Active ingredient added : Pine (40 mg)
- Active ingredient added : Total Flavonoids (720 mg)
- Active ingredient removed : Butcher's Broom Rhizome, Root Extract (80 mg)
- Active ingredient removed : Grape Seed Extract (10 mg)
- Active ingredient removed : Horse Chestnut Seed Extract (80 mg)
- Active ingredient removed : Pine Bark Extract (10 mg)
- Different quantity per serving : Hesperidin: 100 mg in this version; 50 mg on the displayed label
- Different quantity per serving : Rutin: 20 mg in this version; 10 mg on the displayed label
Official label: Circulation & Vein Support For Healthy Legs
Entered into DSLD on 24 March 2016. Withdrawn from the US market on 16 December 2016 (according to the DSLD).- Active ingredient added : Butcher’s Broom (40 mg)
- Active ingredient added : Grape (40 mg)
- Active ingredient added : Pine (40 mg)
- Active ingredient added : Total Flavonoids (720 mg)
- Active ingredient removed : Butcher's Broom Rhizome, Root Extract (80 mg)
- Active ingredient removed : Grape Seed Extract (10 mg)
- Active ingredient removed : Horse Chestnut Seed Extract (80 mg)
- Active ingredient removed : Pine Bark Extract (10 mg)
- Different quantity per serving : Hesperidin: 100 mg in this version; 50 mg on the displayed label
- Different quantity per serving : Rutin: 20 mg in this version; 10 mg on the displayed label
Official label: Circulation & Vein Support For Healthy Legs
Entered into DSLD on 26 February 2014. Withdrawn from the US market on 26 January 2016 (according to the DSLD).- Active ingredient added : Butcher’s Broom (40 mg)
- Active ingredient added : Grape (40 mg)
- Active ingredient added : Pine (40 mg)
- Active ingredient added : Total Flavonoids (720 mg)
- Active ingredient removed : Butcher's Broom Rhizome, Root Extract (80 mg)
- Active ingredient removed : Grape Seed Extract (10 mg)
- Active ingredient removed : Horse Chestnut Seed Extract (80 mg)
- Active ingredient removed : Pine Bark Extract (10 mg)
- Different quantity per serving : Hesperidin: 100 mg in this version; 50 mg on the displayed label
- Different quantity per serving : Rutin: 20 mg in this version; 10 mg on the displayed label
Official label: Circulation & Vein Support For Healthy Legs
Entered into DSLD on 25 January 2012. Withdrawn from the US market on 1 January 2012 (according to the DSLD).- Active ingredient added : Butcher’s Broom (40 mg)
- Active ingredient added : Grape (40 mg)
- Active ingredient added : Pine (40 mg)
- Active ingredient added : Total Flavonoids (720 mg)
- Active ingredient removed : Butcher's Broom Rhizome, Root Extract (80 mg)
- Active ingredient removed : Grape Seed Extract (10 mg)
- Active ingredient removed : Horse Chestnut Seed Extract (80 mg)
- Active ingredient removed : Pine Bark Extract (10 mg)
- Different quantity per serving : Hesperidin: 100 mg in this version; 50 mg on the displayed label
- Different quantity per serving : Rutin: 20 mg in this version; 10 mg on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Horse Chestnut Seed Extract
Read the warning, when it applies and the studies cited
Horse Chestnut - Aesculus Hippocastanum
Route of administration: Oral (Bradley 2006; ESCOP 2003)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Known adverse reactions
When using this product you may experience headache, dizziness, gastric irritation, or itchiness (Bradley 2006; Mills and Bone 2005; ESCOP 2003).
Sources cited by Health Canada (3)
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
- Rutin
Read the warning, when it applies and the studies cited
RUTIN
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (PDR 2008).
Sources cited by Health Canada (1)
- PDR 2008: Hendler SS, Rorvik D. PDR for Nutritional Supplements. 2nd edition. Montvale (NJ): Thomson Healthcare; 2008.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : ProCaps Laboratories
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Circulation & Vein Support for Healthy Legs : étiquette retirée du marché américain (ProCaps Laboratories): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/dsld-320070-circulation-vein-support-for-healthy-legs-procaps-laboratori, updated 14 February 2025.